Royalty Pharma plc financial metrics

Professional SEC-based dashboard for profitability, financial health, and growth with transparent scoring logic. Latest period: Q4 2025.

Symbol
RPRX on Nasdaq
Location
New York, NY
Fiscal year end
31 December
Latest financial report
11 Feb 2026

Shareable Research Card

RPRX - Royalty Pharma plc Financial Facts

RPRX - Royalty Pharma plc has a source-backed company facts page for reviewing reported financial metrics, periods, and linked metric histories.

Start with the latest metric summary, then open metric histories or cross-company rankings to compare the same SEC-backed facts.

Context
Latest metrics period: Q4 2025
Latest reported value
Return On Equity 7.7%

Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Open metric pages to inspect the reported history.

Open stable link Open latest 10-Q/10-K hub Which companies report the highest revenue?

Quick Takeaways

  • RPRX - Royalty Pharma plc financial facts are built from SEC company filings data.
  • Latest metrics period on this page: Q4 2025.
  • Headline metric: Return On Equity 7.7%.

What Changed

  • Return On Equity YoY change: <span class="text-red-600">-8.6%</span>.
  • Most recent SEC facts end date: 31 Dec 2025.

Why This Matters

  • This gives a beginner-friendly first read before you inspect detailed formulas and metric tables.
  • Every metric card links to a deeper SEC-backed history page for verification.

Source Evidence

Based on latest 10-Q/10-K

Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Open company facts to inspect the reported metric history.

See Original Filing

Latest SEC snapshot (2025-12-31) highlights Return On Equity 7.7%, Return On Assets 4.1%, and Operating Margin 65.6%.

Compare This Company Through SEC-backed Metrics

Use these links to compare RPRX - Royalty Pharma plc against other SEC filers on the same metric, then verify the company history from the paired facts page.

Financial Quality Score

Transparent 0-100 scoring model based on profitability, financial health, and growth factors.

36.5/100

Weak Confidence medium

Return On Equity

7.7%

Metric score 0.0/100

Return On Assets

4.1%

Metric score 25.9/100

Financial Health

Current Ratio
2.4x

Strengths

Operating Margin and Current Ratio

Watchpoints

Return On Equity, Return On Assets, and NetIncomeLoss YoY

Key metrics snapshot

Return On Equity

7.7%

YoY: -8.6%

Industry median: -43% (n=675)

View history

Return On Assets

4.1%

YoY: -18%

Industry median: -47% (n=673)

View history

Operating Margin

66%

YoY: +15%

Industry median: -121% (n=298)

View history

Current Ratio

2.4x

YoY: +67%

Industry median: 3.39x (n=667)

View history

Revenues YoY

5.1%

YoY:

Industry median: 7.3% (n=302)

View history

NetIncomeLoss YoY

-10%

YoY:

Industry median: -0.93% (n=641)

View history

Profitability

Metric Latest value YoY change
Return On Equity 7.7% -8.6%
Return On Assets 4.1% -18%
Operating Margin 66% +15%

Financial Health

Metric Latest value YoY change
Current Ratio 2.4x +67%

Growth

Metric Latest value YoY change
Revenues YoY 5.1%
NetIncomeLoss YoY -10%

Share Metrics

Metric Latest value YoY change
Weighted Average Number of Shares Outstanding, Basic 429,801,000 -4.1%
Weighted Average Number of Shares Outstanding, Diluted 564,455,000 -5%

Additional Metrics

Metric Latest value YoY change
Research and Development Expense $452,000,000 +22500%
General and Administrative Expense $573,481,000 +142%
Costs and Expenses $818,675,000 -16%
Operating Income (Loss) $1,559,518,000 +21%
Nonoperating Income (Expense) $235,326,000 -713%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $1,324,192,000 -0.5%
Income Tax Expense (Benefit) $0
Earnings Per Share, Basic 1.79 -6.8%
Earnings Per Share, Diluted 1.78 -6.8%
Cash and Cash Equivalents, at Carrying Value $618,696,000 -33%
Other Assets, Current $6,893,000 +65%
Assets, Current $1,528,091,000 -15%
Goodwill $924,634,000
Other Assets, Noncurrent $79,293,000 +136%
Assets $19,620,780,000 +7.7%
Liabilities, Current $636,211,000 -49%
Other Liabilities, Noncurrent $120,843,000 +900%
Liabilities $9,905,841,000 +26%
Retained Earnings (Accumulated Deficit) $2,356,318,000 -17%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $9,714,939,000 -6.1%
Liabilities and Equity $19,620,780,000 +7.7%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $618,696,000 -33%
Operating Lease, Liability $19,257,000
Lessee, Operating Lease, Liability, to be Paid $22,160,000
Lessee, Operating Lease, Liability, to be Paid, Year Two $3,776,000
Lessee, Operating Lease, Liability, to be Paid, Year One $4,053,000
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $2,903,000
Lessee, Operating Lease, Liability, to be Paid, Year Three $3,721,000
Lessee, Operating Lease, Liability, to be Paid, Year Four $3,726,000
Additional Paid in Capital $4,123,088,000 +0.48%

How we score

This score is transparent and deterministic. We weight profitability, financial health, and growth metrics, then renormalize weights when SEC data is missing.

Metric Weight V1 threshold
ROIC205% to 20%
ROE158% to 25%
ROA102% to 10%
Operating Margin55% to 25%
Current Ratio121.0x to 2.0x
Quick Ratio80.8x to 1.5x
Debt to Equity100.3x to 2.0x (lower is better)
Revenue YoY10-10% to +20%
Net Income YoY10-10% to +20%

How Calculated (standard_v1)

Metrics are computed with a market-consensus convention designed for cross-portal comparability.

  • TTM Operating Income / TTM Revenues
  • Current Assets / Current Liabilities (latest instant quarter)
  • (Current Assets - Inventory) / Current Liabilities; fallback: (Cash+Short-Term Investments + Accounts Receivable) / Current Liabilities
  • Total Debt / Stockholders Equity (latest instant quarter; shared unit; freshest series)
  • TTM Net Income / Average Equity (current quarter + same quarter previous year) / 2
  • TTM Net Income / Average Assets (current quarter + same quarter previous year) / 2
  • TTM NOPAT / Average Invested Capital, where NOPAT=Operating Income*(1-tax rate), Invested Capital=Equity+Total Debt-Cash & ST Investments
  • TTM Revenues YoY
  • TTM Net Income YoY